期刊文献+

重组白细胞介素-4增强日本血吸虫组织蛋白酶B核酸疫苗诱导小鼠的保护力 被引量:4

Boost Effect of Recombinant IL-4 on Protection of Schistosoma japonicum Cathepsin B DNA Vaccine in Mice Against the Parasite
下载PDF
导出
摘要 目的探讨重组白细胞介素-4(IL-4)真核表达质粒增强日本血吸虫组织蛋白酶BDNA疫苗对小鼠的免疫保护效果。方法将小鼠IL-4基因克隆至真核表达载体pcDNA3.1以构建小鼠重组IL-4表达质粒,并联合日本血吸虫组织蛋白酶B的表达质粒DNA(VR1012-Sj31)肌注免疫小鼠,设重组IL-4表达质粒、组织蛋白酶B表达质粒和2种空载体质粒对照组。免疫组化检测IL-4和组织蛋白酶B在小鼠肌细胞内的表达,末次免疫3周后攻击感染,用减虫率及减卵率表示保护力。结果重组IL-4和组织蛋白酶BDNA均在小鼠肌细胞表达,重组IL-4和组织蛋白酶BDNA联合免疫小鼠,产生43.2%的减虫率和76.6%的减卵率,与组织蛋白酶BDNA单独免疫相比差异有显著性(P<0.01,P<0.05)。结论重组IL-4能提高日本血吸虫组织蛋白酶B核酸疫苗的抗血吸虫保护力作用,具有佐剂的免疫效应。 Objective To investigate the enhancement effect of IL-4 expression plasmid on cathepsin B DNA vaccine of Schistosoma japonicum (Sj) in mice. Methods The recombinant IL-4 plasmid constructed by cloning PCR amplified product of murine IL-4 gene into eukaryotic expression vector pcDNA3.1 was co-injected intramuscularly with Sj cathepsin B expression plasmid DNA to mice as the test group. The other three groups of mice were set up as control including IL-4 expression plasmid, Sj cathepsin B expression plasmid and two vacant vector plasmids. The expression of IL-4 and cathepsin B was visualized by immunohistochemistry. Challenge infection in mice was carried out 3 weeks after the last vaccination and immune protection was assessed by worm and egg reduction rates. Results The recombinant mIL-4 plasmid and cathepsin B DNA vaccine were expressed in muscular cells of the vaccinated mice. Immunization with cathepsin B DNA plus recombinant mIL-4 plasmid yielded a 43.2 % of worm reduction rate and a 76.6% of egg reduction rate, showing a significant difference(P<0.01, P<0.05) compared with that of cathepsin B DNA vaccine alone. Conclusion As an adjuvant, IL-4 DNA can improve the protective effect of cathepsin B DNA vaccine in mice against S. japonicum infection.
出处 《中国寄生虫学与寄生虫病杂志》 CAS CSCD 北大核心 2005年第2期65-68,共4页 Chinese Journal of Parasitology and Parasitic Diseases
基金 世界卫生组织/热带病研究与培训规划署(WHO/TDR)资助项目(ID980268)~~
  • 相关文献

参考文献20

  • 1易新元,曾宪忠,曾宪芳,汪世平,舒新华,LarryMcreynolds.日本血吸虫组织蛋白酶BDNA疫苗抗生殖免疫的研究[J].中国人兽共患病杂志,2000,16(1):45-47. 被引量:37
  • 2Brindley PJ, Kalina BH, Dalton JP, et al. Proteolytic degradation of host hemoglobin by schistosomes[J]. Mol Biochem Parasitol, 1997,89:1-9.
  • 3Verity CK, McManus DP, Brindley PJ. Vaccine efficacy of recombinant cathepsin D aspartic protease from Schistosoma japonicum[J]. Parasit Immunol,2001, 23:153-162.
  • 4Verity CK, McManus DP, Brindley PJ. Cellular responses to Schistosoma japonicum cathepsin D aspartic protease[J]. Parasit Immunol,2002, 24:363-367.
  • 5La Flamme AC, MacDonald AS, Huxtable CR, et al. Lack of C3 affects Th2 response development and the sequelae of chemotherapy in schistosomiasis[J]. J Immunol,2003,170: 470-476.
  • 6Caldas IR, Correa-Oliveira R, Colosimo E, et al. Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment[J]. Am J Trop Med Hyg,2000, 62:57-64.
  • 7Hoffmann KF, James SL, Cheever AW, et al. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni[J]. J Immunol, 1999, 163:927-938.
  • 8Hagan P, Blumenthal U J, Dunn D, et al. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium[J]. Nature,1991, 349: 243-245.
  • 9Hagi H, Huldt G, Loftenius A, et al. Antibody responses in schistosomiasis haematobium in Somalia. Relation to age and infection intensity[J]. Ann Trop Med Parasitol,1990, 84:171-179.
  • 10Rihet P, Demeure CE, Bourgois A, et al. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels[J]. Eur J Immunol, 1991, 21:2679-2686.

二级参考文献5

共引文献36

同被引文献94

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部